Showing results 164 to 183 of 261
< previous
next >
Preview | Issue Date | Title | Author(s) | Access |
![ALEO ROSELLÓ, ANA.pdf.jpg](/jspui/retrieve/5e6b6e2e-0225-4d1e-8c46-a284f781c9ea/ALEO%20ROSELL%c3%93%2c%20ANA.pdf.jpg) | 19-Jun-2018 | Papel del sistema inmunitario en enfermedad hepática | Aleo Roselló, Ana | ![](/image/openAccess.png) |
![Santos Rodrigálvarez, Marta.pdf.jpg](/jspui/retrieve/668095f5-2b2b-4431-83cd-aaab7a403432/Santos%20Rodrig%c3%a1lvarez%2c%20Marta.pdf.jpg) | 23-May-2023 | El papel inmunomodulador de los antígenos de Anisakis en el ser humano. | Santos Rodrigálvarez, Marta | ![](/image/openAccess.png) |
![tfg Matarredona Jordá, Malena.pdf.jpg](/jspui/retrieve/05b7d646-5a82-4a07-b802-3fe2901cffb9/tfg%20Matarredona%20Jord%c3%a1%2c%20Malena.pdf.jpg) | 23-May-2022 | Papel terapéutico de los anticuerpos conjugados en el tratamiento del cáncer | Matarredona Jordá, Malena | ![](/image/openAccess.png) |
![CORTÉS RUIZ, MIRIAM, TFG.pdf.jpg](/jspui/retrieve/d099eb2d-0303-41a6-8cec-6af612ccac71/CORT%c3%89S%20RUIZ%2c%20MIRIAM%2c%20TFG.pdf.jpg) | 25-May-2022 | Perfil clínico y epidemiológico del paciente pediátrico COVID-19 en el departamento de salud Elx | Cortés Ruiz, Miriam | ![](/image/openAccess.png) |
![TD Gutiérrez Moreno, David.pdf.jpg](/jspui/retrieve/0a753416-f8ed-4036-b727-43399f9155fd/TD%20Guti%c3%a9rrez%20Moreno%2c%20David.pdf.jpg) | 22-Sep-2017 | Perilenodiimidas: Funcionalización directa de las posiciones bahía con compuestos nitrogenados | Gutiérrez Moreno, David | ![](/image/openAccess.png) |
![Personality and psychiatric disorders in chronic pain male affected.pdf.jpg](/jspui/retrieve/7cce012c-d596-46f4-97fd-a125c9de19e0/Personality%20and%20psychiatric%20disorders%20in%20chronic%20pain%20male%20affected.pdf.jpg) | May-2020 | Personality and psychiatric disorders in chronic pain male affected by erectile dysfunction: prospective and observational study | Ajo Ferrer, Raquel; Inda, Maria del Mar; Mateu, Margarita; Segura, Ana; Ballester, Purificación; Muriel, Javier; Sellers, Rafael; Ferrández, Guillermina; Margarit, César; Peiró, Ana | ![](/image/closedAccess.png) |
![Personalized medicine into health national.pdf.jpg](/jspui/retrieve/835f90ed-3e0a-463e-8c9f-b70e0e3bd957/Personalized%20medicine%20into%20health%20national.pdf.jpg) | 19-Dec-2018 | Personalized medicine into health national services: barriers and potentialities | Rodríguez-Vicente, Ana E; Herrero Cervera, Maria José; Bernal, María Luisa; Rojas, Luis; Peiró, Ana | ![](/image/openAccess.png) |
![Ortiz Marcos, Carlos.pdf.jpg](/jspui/retrieve/68c71f77-e13e-40df-8bbf-fd05a1f014f3/Ortiz%20Marcos%2c%20Carlos.pdf.jpg) | 19-May-2022 | Perspectivas terapéuticas en el tratamiento del Trastorno por Déficit de Atención e Hiperactividad (TDAH) con fitocannabinoides. | Ortiz Marcos, Carlos | ![](/image/openAccess.png) |
![Pharmacogenetic Guided Opioid Therapy Improves Chronic.pdf.jpg](/jspui/retrieve/1772878b-270e-4cd7-bc03-a7cb5fee6471/Pharmacogenetic%20Guided%20Opioid%20Therapy%20Improves%20Chronic.pdf.jpg) | 2023 | Pharmacogenetic Guided Opioid Therapy Improves Chronic Pain Outcomes and Comorbid Mental Health: A Randomized, Double-Blind, Controlled Study | Agulló, Laura; Aguado, Isidro; Muriel, Javier; Margarit, César; Gómez, Alba; Escorial, Mónica; Sánchez, Astrid; Fernández, Alicia; Peiró, Ana | ![](/image/openAccess.png) |
![Pharmacogenetics and prediction of adverse events in.pdf.jpg](/jspui/retrieve/57275c95-8b6e-4e03-a7db-9b305d1d5d13/Pharmacogenetics%20and%20prediction%20of%20adverse%20events%20in.pdf.jpg) | 2018 | Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patients | Muriel, Javier; Margarit, César; Barrachina, Jordi; Ballester, Purificación; Flor, Andrea; Morales, Domingo; Horga, José F.; Fernández, Eduardo; Peiró, Ana | ![](/image/closedAccess.png) |
![DE MIGUEL LÓPEZ, LAURA, TFG.pdf.jpg](/jspui/retrieve/1ec1c55f-351f-4095-bdf2-103c567fd7df/DE%20MIGUEL%20L%c3%93PEZ%2c%20LAURA%2c%20TFG.pdf.jpg) | 3-May-2023 | Pharmacogenetics for psychotropic drugs and a cross-sectional study of adverse events in autism spectrum disorder | de Miguel López, Laura | ![](/image/openAccess.png) |
![Pharmacogenetics May Prevent Psychotropic Adverse Events in Autism Spectrum Disorder. An Observational Pilot Study.pdf.jpg](/jspui/retrieve/8e029221-b410-4198-8f90-2cc542393bc7/Pharmacogenetics%20May%20Prevent%20Psychotropic%20Adverse%20Events%20in%20Autism%20Spectrum%20Disorder.%20An%20Observational%20Pilot%20Study.pdf.jpg) | 20-Oct-2023 | Pharmacogenetics May Prevent Psychotropic Adverse Events in Autism Spectrum Disorder: An Observational Pilot Study | Miguel, Laura de; Ballester, Purificación; Egoavil, Cecilia; Sánchez-Ocaña, María Luisa; García-Muñoz, Ana María; Cerdá, Begoña; ZAFRILLA, PILAR; Ramos, Enrique; Peiró, Ana | ![](/image/openAccess.png) |
![Pharmacogenomics and prescription opioid.pdf.jpg](/jspui/retrieve/96d89889-1a3a-47f7-aff1-9f9fe20e0425/Pharmacogenomics%20and%20prescription%20opioid.pdf.jpg) | Mar-2021 | Pharmacogenomics and prescription opioid use | Benjeddou, Mongi; Peiró, Ana | ![](/image/closedAccess.png) |
![Juan Ramón Pol Calderón. TFG. 2024.pdf.jpg](/jspui/retrieve/fe634741-d14b-409e-a892-2e80495fb772/Juan%20Ram%c3%b3n%20Pol%20Calder%c3%b3n.%20TFG.%202024.pdf.jpg) | 21-May-2024 | Posibles alternativas a las benzodiacepinas en el manejo de la ansiedad | Pol Calderón, Juan Ramón | ![](/image/openAccess.png) |
![TFG FINAL Rym Feryal Amara.pdf.jpg](/jspui/retrieve/2397d7e6-b118-40c2-9485-e2dcc09689a4/TFG%20FINAL%20Rym%20Feryal%20Amara.pdf.jpg) | 18-Aug-2023 | Posibles aspectos terapéuticos de los cannabinoides en el dolor neuropático: Revisión de alcance. | Amara Hadj Messaoud, Rym Feryal | ![](/image/openAccess.png) |
![TFG - Isabel Parres Cosma.pdf.jpg](/jspui/retrieve/797dd085-4dc5-44c4-8821-7b05d4df302e/TFG%20-%20Isabel%20Parres%20Cosma.pdf.jpg) | 22-May-2024 | Potencial terapéutico de compuestos cannabinoides en el abordaje del dolor oncológico | Parres Cosma, Isabel | ![](/image/openAccess.png) |
![Martín García, Araceli.pdf.jpg](/jspui/retrieve/8c50b79e-bfa6-4eda-9391-f990ba9c3799/Mart%c3%adn%20Garc%c3%ada%2c%20Araceli.pdf.jpg) | 21-May-2024 | Potencial terapéutico del cannabidiol en el trastorno por uso de opioides | Martín García, Araceli | ![](/image/openAccess.png) |
![Daniel Carretero Moraleda-TFG.pdf.jpg](/jspui/retrieve/a1acdc80-5988-4f22-9bee-28a66e9da6b4/Daniel%20Carretero%20Moraleda-TFG.pdf.jpg) | 24-May-2023 | Potencial terapéutico del cannabidiol en la enfermedad de Parkinson | Carretero Moraleda, Daniel | ![](/image/openAccess.png) |
![TFG_ÁlvaroPuertasCaruana.pdf.jpg](/jspui/retrieve/621b8777-dea8-4f8b-ab05-1f1d21aa2138/TFG_%c3%81lvaroPuertasCaruana.pdf.jpg) | 17-May-2023 | Potencial utilidad del cannabidiol en la abstinencia inducida por el consumo de cannabis | Puertas Caruana, Álvaro | ![](/image/openAccess.png) |
![2020 7 DAP MONTES.pdf.jpg](/jspui/retrieve/44c6990e-3e75-44a6-aea8-63c99d648d86/2020%207%20DAP%20MONTES.pdf.jpg) | 2020 | Presurgical risk model for chronic postsurgical pain
based on 6 clinical predictors: a prospective
external validation | Montes, Antonio; Roca, Gisela; Cantillo, Jordi; Sebate, Sergi | ![](/image/closedAccess.png) |